Company / Operating Income
Century Therapeutics, Inc. Operating Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$138.1M
FY2025
5-year range
-$146.5M / -$94.9M
FY2022-FY2025
Trend
+5.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2025 after 2 years of decline, reaching -$138M.
Based on SEC 10-K filings.
-$138M in FY2025.
Declined from -$134M to -$138M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 5.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$138.1M | +5.7% |
| FY2024 | -$146.5M | -9.5% |
| FY2023 | -$133.8M | -41.0% |
| FY2022 | -$94.9M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026